Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice
Ali M, Johnson M, Irwin T, Henry S, Sugeng L, Kansal S, Allison T, Bremer M, Jones V, Martineau M, Wong C, Marecki G, Stebbins J, Michelena H, McCully R, Svatikova A, Padang R, Scott C, Kanuga M, Arsanjani R, Pellikka P, Kane G, Thaden J. Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice. Journal Of The American Society Of Echocardiography 2023, 37: 276-284.e3. PMID: 37879379, DOI: 10.1016/j.echo.2023.10.010.Peer-Reviewed Original ResearchConceptsUltrasound enhancing agentsAdverse drug reactionsSevere adverse drug reactionsDrug reactionsEchocardiography databaseHealth systemFrequency of severe adverse drug reactionsIsolated back painUS health systemST-segment elevationIncidence of severe adverse drug reactionsLoss of pulseCardiopulmonary involvementLoss of consciousnessMRNA vaccinesLumasonMatched ControlsRare riskEnhancing agentsADR rateProspective reportsCOVID-19 vaccineAdministrationPainHeadache
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply